close

Enter

Log in using OpenID

RNA Based Therapeutics and Vaccines Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
Global RNA based therapeutics and vaccines market to value over USD 800 Million by 2029 end and register a CAGR of over 58.4% from 2019 to 2029. The market for RNA based therapeutics and vaccines are anticipated to boost due to the extensive researc
RNA Based Therapeutics and Vaccines Market Global Trends, Market Share,
Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
Global RNA based therapeutics and vaccines market to value over USD 800 Million by
2029 end and register a CAGR of over 58.4% from 2019 to 2029.
The market for RNA based therapeutics and vaccines are anticipated to boost due to
the extensive research undertaken by the firms. This research is supported and aided
by various strong governmental as well as private institutional organisations over a
significant period. Various firms have recognised the potential of the untapped
market of RNA based therapeutics and started exploring into the sector thus
expanding the geographical reach of the market worldwide. Therapeutics for specific
targets and rare diseases are highly in demand as the medical industry offer only a
limited range of therapeutics and vaccines without alternatives for, especially rare
diseases. Many firms are thus constantly innovating and researching new cures and
drugs for these rare diseases, through collaborations, in order to gain maximum
revenue in this industry. For instance, Regeneron Pharmaceuticals, Inc. and Alnylam
Pharmaceuticals, Inc. announced a strategic collaboration for RNAi therapeutics
development in order to target the chronic liver disease nonalcoholic steatohepatitis
(NASH).
RNA based therapeutics and vaccines are projected to emanate as potential
substitutes of traditional symptomatic therapeutics against unforeseen ailments.
Significant firms holding major market share are focusing on RNA molecule
development for rare medical conditions. In order to reduce manufacturing costs,
companies are outsourcing their raw material. This is highly beneficial given the
substantial reduction of raw material costs, simple manufacturing processes, and
advanced technology are factors to create an opportunistic space for RNA based
therapeutics manufacturers. The firms operating in the market are expected to have
ROI due to limited competition in the global market.
Several market influencers are also identified to be concentrating on the codevelopment of RNA therapeutics and vaccines in association with pharma leaders to
accelerate trade and research activities. In 2018, Arbutus Biopharma Corporation, a
publicly-traded biopharmaceutical company with expertise in liposomal drug delivery
and RNA interference and Gritstone Oncology, who is developing tumor-specific
cancer immunotherapies to fight multiple cancer types, entered a collaboration and
license agreement with an aim to extend the former’s proprietary lipid nanoparticle
(LNP) technology to deliver the latter’s RNA-based neoantigen immunotherapy
products.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=264&page=requestsample
RNA based Therapeutics and Vaccines Market: Segmentation
By Product Type
● RNA-based Therapeutics
> siRNA
>miRNA
● RNA-based Vaccines
> mRNA
By Indication Type
● Oncology
● Immunology
● Ophthalmology
● Cardiovascular Diseases
● Infectious Diseases
● Genetic Diseases
● Others
By Region:
● Europe
● North America
● APAC
● Latin America
● Rest of World
North America holds the major share in the RNA based therapeutics and vaccines
market due to the increasing incidence in ailments and ready adoption of
technologies. Extensive research is done in order to commercialize the therapeutics
while hefty investment undertaken for research and advancement in RNA based
technologies coupled with the support provided by the various organisations is
helping the market in the region to grow at a steady rate. However, the business
dynamics present in the Asia Pacific is expected to provide a lucrative opportunity in
the global market of RNA based therapeutics and vaccines owing to the less cost
required for clinical research in comparison to North America and Europe.
Purchase a Copy of this Premium Research Report At:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=264&license=single
Competitive Landscape:
● Tier 1 players- established companies in the market with a major market share
● Tier 2 players
● Emerging players which are growing rapidly
● New Entrants
Significant firms in the market are Sylentis S.A., Moderena Therapeutics, Inc., mirage
Therapeutics, Regulus Therapeutics, Inc., and Arbutus Biopharma Corp.
FutureWise Key Takeaways
● Growth prospects
● SWOT analysis
● Key trends
● Key data points affecting market growth
Objectives of the Study:
● To provide an exhaustive analysis on RNA based therapeutics and vaccines
market based on product type, indication and region
● To cater comprehensive information on factors impacting market growth
(drivers, restraints, opportunities, and industry-specific restraints)
● To evaluate and forecast micro-markets and overall market
● To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East and Africa
● To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
● Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
3
File Size
16 KB
Tags
healthcare, health
1/--pages
Report inappropriate content